About us
Nemaura Medical Inc. (NMRD) is a NASDAQ-listed British medical technology company based in Loughborough, UK.
Developers of sugarBEAT®, a non-invasive, affordable and flexible continuous glucose monitor (CGM). This CE mark approved, Class IIb medical device, provides actionable insights which may help people with Diabetes and Pre-diabetes to better manage, reverse and prevent the onset of Diabetes.
Both users and medical professionals can make use of its real time glucose measurements, and daily glucose trend data, to manage wellness plans and change behaviour. By making the device comfortable and convenient, and omitting the need for fingerstick testing, we’re improving users’ quality of life and empowering them to self-manage. Meanwhile, the flexible system reduces Sensor wear time and subsequently reduces healthcare costs.